V028-2585 Screening compound: N-[(4-fluorophenyl)methyl]-1-(3-methoxybenzoyl)-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carboxamide

V028-2585 Screening compound: N-[(4-fluorophenyl)methyl]-1-(3-methoxybenzoyl)-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carboxamide
V028-2585 Screening compound: N-[(4-fluorophenyl)methyl]-1-(3-methoxybenzoyl)-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-2585
N-[(4-fluorophenyl)methyl]-1-(3-methoxybenzoyl)-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-2585

Molecular Formula

C29H31FN2O6 (C29 H31 FN2 O6)

Compound Name

N-[(4-fluorophenyl)methyl]-1-(3-methoxybenzoyl)-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carboxamide

IUPAC name

N-[(4-fluorophenyl)methyl]-1-(3-methoxybenzoyl)-4-(345-trimethoxyphenyl)pyrrolidine-3-carboxamide

SMILES

COc1cccc(C(N(CC2C(NCc(cc3)ccc3F)=O)CC2c(cc2OC)cc(OC)c2OC)=O)c1

InChI

InChI=1S/C29H31FN2O6/c1-35-22-7-5-6-19(12-22)29(34)32-16-23(20-13-25(36-2)27(38-4)26(14-20)37-3)24(17-32)28(33)31-15-18-8-10-21(30)11-9-18/h5-14,23-24H,15-17H2,1-4H3,(H,31,33)

InChI Key

BYWKWJNQVVXBEG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14261080

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

522.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.176

Distribution Coefficient, logD

3.176

Water Solubility, LogSw

-3.36

Polar Surface Area

71.783

Acid Dissociation Constant (pKa)

11.47

Base Dissociation Constant (pKb)

-3.50

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

31.00

V028-2585 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V028-2585 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-2585?
Check Price and Availability of V028-2585, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-2585 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-2585
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-2585
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-2585 available by request